TY - JOUR
T1 - β-thalassemia major and its effect on amino acid metabolism and growth in patients in the United Arab Emirates
AU - Abdulrazzaq, Yousef M.
AU - Ibrahim, Ahmed
AU - Al-Khayat, Abdulla I.
AU - Dawson, Kenneth
PY - 2005/2
Y1 - 2005/2
N2 - There may be a marked reduction in essential amino acids in the serum of children with thalassemia major and this is related to decreased growth in affected children. One hundred patients with β-thalassemia and 50 control children selected from among those who had presented with minor disorders unrelated to hematological disease were recruited. Urine and heparinized blood were collected from fasting thalassemic patients. After deproteinization and dilution, amino acid concentrations were measured using ion-exchange chromatography. Isoleucine (p<0.0001), phenylalanine (p<0.05), tyrosine (p<0.0001), taurine (p<0.0001) and glutamine (p<0.01) were significantly decreased in the plasma of thalassemic patients compared to the control group. Whereas glutamate (p<0.0001), serine (p<0.05) and proline (p<0.05) were significantly higher in thalassemic patients, threonine, glycine, alanine, valine, methionine, leucine, ornithine, lysine, histidine and arginine values were not different. The essential amino acids taurine (p<0.0001), methionine (p<0.01), valine (p<0.01), phenylalanine (p<0.01) and leucine (p<0.05) were significantly decreased in urine of thalassemic patients vs. controls, but threonine and ornithine were not different. The mean urinary excretion rate of β-aminoisobutyric acid was not different (69±96 in thalassemics vs. 41±52 in controls). However, most plasma and urinary essential amino acids were found to be lower in thalassemics. Thalassemic patients were also found to be significantly growth impaired for age, both in height and weight compared to controls. Lower plasma values of essential amino acids and a decrease in urinary amino acids occur in thalassemic patients. Growth impairment both in height and weight also occurs in thalassemic patients compared to a control population.
AB - There may be a marked reduction in essential amino acids in the serum of children with thalassemia major and this is related to decreased growth in affected children. One hundred patients with β-thalassemia and 50 control children selected from among those who had presented with minor disorders unrelated to hematological disease were recruited. Urine and heparinized blood were collected from fasting thalassemic patients. After deproteinization and dilution, amino acid concentrations were measured using ion-exchange chromatography. Isoleucine (p<0.0001), phenylalanine (p<0.05), tyrosine (p<0.0001), taurine (p<0.0001) and glutamine (p<0.01) were significantly decreased in the plasma of thalassemic patients compared to the control group. Whereas glutamate (p<0.0001), serine (p<0.05) and proline (p<0.05) were significantly higher in thalassemic patients, threonine, glycine, alanine, valine, methionine, leucine, ornithine, lysine, histidine and arginine values were not different. The essential amino acids taurine (p<0.0001), methionine (p<0.01), valine (p<0.01), phenylalanine (p<0.01) and leucine (p<0.05) were significantly decreased in urine of thalassemic patients vs. controls, but threonine and ornithine were not different. The mean urinary excretion rate of β-aminoisobutyric acid was not different (69±96 in thalassemics vs. 41±52 in controls). However, most plasma and urinary essential amino acids were found to be lower in thalassemics. Thalassemic patients were also found to be significantly growth impaired for age, both in height and weight compared to controls. Lower plasma values of essential amino acids and a decrease in urinary amino acids occur in thalassemic patients. Growth impairment both in height and weight also occurs in thalassemic patients compared to a control population.
KW - β thalassemia
KW - Amino acid
KW - Growth
KW - UAE
UR - http://www.scopus.com/inward/record.url?scp=11844260631&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=11844260631&partnerID=8YFLogxK
U2 - 10.1016/j.cccn.2004.09.017
DO - 10.1016/j.cccn.2004.09.017
M3 - Article
C2 - 15653113
AN - SCOPUS:11844260631
SN - 0009-8981
VL - 352
SP - 183
EP - 190
JO - Clinica Chimica Acta
JF - Clinica Chimica Acta
IS - 1-2
ER -